Beakers Blog  Novo Nordisk

JPM Conference: Bay area biotechs show promise, in their own backyard

by Jeffrey Clark on January 10, 2013

Onyx Pharmaceuticals stock is up 9% in the past ten days, better than most annual gains in the biotechnology industry. Onyx CEO Tony Coles explains why from the JP Morgan Healthcare conference.

Questcor, Dendreon and Biomarin are three of the hottest companies in biotechnology over the past year. Biomarin CEO JJ Bienaime discusses the reason behind his company’s 25% surge in the last 3 months.

Leave a Comment

Previous post:

Next post: